Blood biomarker levels linked to mortality risk in amyotrophic lateral sclerosis

Takeaway

  • Baseline levels and temporal changes of serum creatinine, albumin, C-reactive protein and glucose are linked to a higher risk of death after amyotrophic lateral sclerosis diagnosis.

Why this matters

    These novel findings suggest that these blood biomarkers routinely measured in clinical practice and clinical trials are potential indicators for amyotrophic lateral sclerosis prognosis.